The perioperative management of metformin for the oral and maxillofacial surgery patient: risks and recommendations.
Blyer
Scott Marshall
SM
Department of Oral and Maxillofacial Surgery, Long Island Jewish Hospital, New Hyde Park, NY, USA. sblyer@yahoo.com
Yelon
Jay A
JA
D000140:Acidosis, Lactic / Q000139:chemically induced / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*; D016343:Monitoring, Intraoperative; D019647:Oral Surgical Procedures; D019990:Perioperative Care; D011183:Postoperative Complications; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D012307:Risk Factors
D007004:Hypoglycemic Agents; D008687:Metformin